GLP1R and Other metabolic disease: Imaging diagnostics using exendin based analogues targeted at GLP-1R in combination with SPECT and PET has proven its clinical value in insulinoma management, while many potential clinical uses in metabolic diseases including diabetes and islets transplantation are under investigation.